课题基金 / 基金详情

项目摘要

项目成果

Robert Walter Buckheit的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Preclinical and Clinical Developmental and Regulatory Evaluations Core (Core B) will be responsible for the provision of test materials for use by all components of the Program, including subcontractors performing animal modeling and toxicology studies, as well as overall Project Management of the regulatory development of the final ring products. Thus, ImQuest BioSciences staff will coordinate the synthesis, storage and shipping of compounds required for evaluation, the interactions with a regulatory consultant responsible for providing advice on the development of the ring product, the performance of safety pharmacology and toxicology testing, including irritation and absorption studies, the synthesis of GMP material for use in the ring product and for submission of the pre-IND and IND documents leading to the pre- Phase 1 human clinical trial.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Determination of Dosing Concentrations of Formulated APIs using the MTSA
  • 批准号:
    8404125
  • 项目类别:
  • 资助金额:
    $33.75万
  • 财政年份:
    2012
  • 负责人:
    Robert Walter Buckheit
  • 依托单位:
Development and Evaluation of Dual Compartment Combination Microbicides
  • 批准号:
    8699496
  • 项目类别:
  • 资助金额:
    $287.64万
  • 财政年份:
    2012
  • 负责人:
    Robert Walter Buckheit
  • 依托单位:
Development and Evaluation of Dual Compartment Combination Microbicides
  • 批准号:
    8862358
  • 项目类别:
  • 资助金额:
    $244.32万
  • 财政年份:
    2012
  • 负责人:
    Robert Walter Buckheit
  • 依托单位:
Critical Path IND-enabling Studies, Regulatory, and Product Development
  • 批准号:
    8405106
  • 项目类别:
  • 资助金额:
    $94.2万
  • 财政年份:
    2012
  • 负责人:
    Robert Walter Buckheit
  • 依托单位:
海外基金